Stem Cell Transplant Clinical Trials in Toronto, Ontario
2 recruitingToronto, Ontario, Canada
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)Solid Organ Transplant ComplicationsLymphoproliferative Disorders+2 more
Pierre Fabre Medicament115 enrolled71 locationsNCT03394365
Recruiting
Not Applicable
Psychoeducation for AlloHCT Caregivers
CopingCancerStem Cell Transplant+2 more
University Health Network, Toronto22 enrolled1 locationNCT07116018